Albany, NY -- (SBWIRE) -- 02/13/2014 -- Molecular diagnostics is defined as a class of diagnostic tests which identifies genetic and molecular biomarkers of an individual patient. It is essentially an analysis of RNA and DNA at the molecular level. This class of diagnostics tests is considered as the most well established and lucrative market in the clinical applications segment. Traditionally, usage of molecular diagnostics was limited due to requirement of highly skilled professionals and high cost of tests. However, recent reduction in cost per sample analysis, labor costs, improvements in automation and introduction of advanced technologies have expanded the usage of molecular diagnostics tests. The growth of this market is expected to surge due to various factors such as rise in incidence of hospital acquired infections, increase in patient awareness along with growing elderly population. Additionally, outbreak of diseases such as H1N1, growing incidence of diseases such as HIV and hepatitis have augmented the growth of this market.
View Full This Report With TOC @ http://www.researchmoz.us/molecular-diagnostics-market-pcr-next-generation-sequencing-microarray-infectious-diseases-genetic-disease-oncology-testing-blood-donor-screening-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019-report.html
The research report on molecular diagnostics provides detailed analysis of the global market and helps in understanding the driving forces responsible for its growth. The report discusses the molecular diagnostics market on the basis of different technologies and applications. The technology segment comprises polymerase chain reaction (PCR), transcription mediated amplification (TMA), hybridization technique, microarray, sequencing and others. The application segment is classified into infectious diseases, blood donor screening and genomics. The genomics segmented is further classified into genetic disorders, oncology, HLA testing and pharmacogenetics testing. The infectious diseases segment comprises market for HIV infections, HAI, HCV infections and others. Market size estimates and forecasts for the period 2011 to 2019 have been provided for each of the segments in terms of USD million using 2012 as the base year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has been provided along with market size estimations.
The market has also been segmented geographically into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW), and respective market sizes and forecasts have been provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global molecular diagnostics market, and future opportunities has been provided in the market overview section. This section also features a detailed market attractiveness analysis and Porter’s five forces analysis for the molecular diagnostics market.
Market players are profiled on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Some of the major players profiled in this report include Abbott Laboratories, Becton Dickinson & Company, Cepheid, Roche Diagnostics and others.
The global molecular diagnosticsmarket is segmented into the following categories:
Molecular DiagnosticsMarket, by Technology:
Transcription mediated amplification (TMA)
Next generation sequencing
Molecular DiagnosticsMarket, by Application:
Genetic testing for inherited disorders
Human Leukocyte Antigen (HLA) testing
Blood Donor Screening
Browse All Latest Report Related to In Vitro Diagnostics Research @ http://www.researchmoz.us/in-vitro-diagnostics-market-reports-28.html
Molecular DiagnosticsMarket, by Geography:
ResearchMoz is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.
For More Information Kindly Contact:
Toll Free: 866-997-4948